News

The Phase II studies are designed to offer valuable insights to guide the selection of the therapeutic indications for which TC-6987 is best suited for later-stage development. The

The study results showed that two distinct twice-daily formulations of DM-1992 maintained therapeutic blood levels of levodopa over 24 hours, Depomed said. Both the formulations are projected, at

Tamiflu capsules are indicated for the treatment of bird and swine flu infections. Natco Pharma and Alvogen believe this is the first substantially completed ANDA filing containing a

UltraTape Industries is a division of Delphon and a supplier of cleanroom tape and labels to the medical/pharmaceutical, aerospace and semiconductor industries. The UltraLabel PRO is versatile and

According to Novo Nordisk, degludec reduces the risk of nocturnal hypoglycemia more than 35% compared with Lantus. Bloomberg.com has quoted Novo Nordisk chief science officer Mads Krogsgaard Thomsen

The recall is a consequence of Health Canada’s Good Manufacturing Practices (GMP) inspection at the company’s Laval manufacturing site where deficiencies in the production line were detected. Possible

Protect still retains the patents related to abuse deterrent and once daily gastro-retentive drug delivery platforms and the corresponding three other ongoing projects. In the near term, Protect

Bioject provides support for efforts to advance clinical research of intradermal delivery of vaccines in developing-country immunization programs to advance the use of DSJIs, reducing risks associated with

mPhase claims that its Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. The